Combined analysis of two studies using the conjunctival allergen challenge model to evaluate olopatadine hydrochloride, a new ophthalmic antiallergic agent with dual activity
- 30 June 1998
- journal article
- clinical trial
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 125 (6) , 797-804
- https://doi.org/10.1016/s0002-9394(98)00044-0
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- TheIn VitroandIn VivoOcular Pharmacology of Olopatadine (AL-4943A), an Effective Anti-Allergic/Antihistaminic AgentJournal of Ocular Pharmacology and Therapeutics, 1996
- Evaluation of 0.05% Levocabastine versus 4% Sodium Cromolyn in the Allergen Challenge ModelOphthalmology, 1995
- Conjunctivitis of allergic origin: Immunologic mechanisms and current approaches to therapySurvey of Ophthalmology, 1993
- Precision of conjunctival provocation tests in right and left eyesJournal of Allergy and Clinical Immunology, 1993
- Allergic Conjunctivitis: A Survey of New AntihistaminesJournal of Ocular Pharmacology and Therapeutics, 1991
- Inflammatory mediator release on conjunctival provocation of allergic subjects with allergenJournal of Allergy and Clinical Immunology, 1990
- Conjunctival Allergen ChallengeArchives of Ophthalmology (1950), 1990
- H2-Receptors in the Human Ocular SurfaceArchives of Ophthalmology (1950), 1981
- Number of Inflammatory Cells in the Normal ConjunctivaAmerican Journal of Ophthalmology, 1978